Johnson & Johnson: News

05 Apr 2023


Johnson & Johnson offers $9B to settle 'talcum-caused cancer' claims 

Pharmaceutical giant Johnson & Johnson (J&J) has been dealing with lawsuits against its talc-based baby powder for years. The company has now offered to pay $8.9 billion to settle the claims of tens of thousands of plaintiffs.

17 Sep 2022


Maharashtra cancels Johnson's baby powder license, company moves court

Maharashtra's Food and Drug Administration (FDA) canceled the baby powder manufacturing license of American pharmaceutical giant Johnson & Johnson Pvt. Ltd. on Friday citing "public health at large."

J&J vaccine's 1cr doses ready for export after CDL nod

American firm Johnson & Johnson's COVID-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18 reported.

15 Sep 2021

COVID-19 Vaccine

35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh.

09 Sep 2021


Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October

The one-dose COVID-19 vaccine developed by American pharma giant Johnson & Johnson and manufactured by the company's local partner, Hyderabad-based Biological E, is likely to be available in India by October, reported News18.

07 Aug 2021

Health & Wellness

J&J's one-dose COVID-19 vaccine gets the nod in India

India has approved Johnson & Johnson's single-dose coronavirus vaccine for emergency use, the Union Health Minister Mansukh Mandaviya announced today.

06 Aug 2021


J&J applies for EUA of COVID-19 vaccine in India

Global healthcare major Johnson & Johnson on Friday said that it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India.

J&J withdraws vaccine approval request in India, CDSCO says

Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.

13 Jul 2021

COVID-19 Vaccine

FDA adds warning of rare reaction risk to J&J vaccine

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction but said it's not entirely clear the shot caused the problem.

02 Jul 2021


Johnson & Johnson says its vaccine works against Delta variant

Johnson & Johnson's one-shot coronavirus vaccine is effective against the highly-contagious Delta variant and provides durable protection against infection overall, the company said in a statement on Thursday.

11 Jun 2021

United Sates

J&J COVID-19 vaccine's expiration date extended by six weeks

Johnson & Johnson said on Thursday that US regulators extended the expiration date on its COVID-19 vaccine doses by six weeks.

19 May 2021


J&J partners with India's Biological E to produce COVID-19 vaccine

American pharmaceutical giant Johnson & Johnson has partnered with the Indian firm Biological E. Limited for the production of its COVID-19 vaccine, a move that could boost the country's overall supplies amid a serious shortage.

12 May 2021


US looking to produce of J&J's COVID-19 vaccine in India

The United States is considering the production of Johnson & Johnson's COVID-19 vaccine in India along with ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, Charge d'Affaires of the US Embassy, said on Tuesday.

24 Apr 2021


US to resume J&J COVID-19 vaccinations despite rare clot risk

US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot, after advisers decided its benefits outweigh a rare risk of a blood clot.

22 Apr 2021


US faces pressure to decide J&J COVID-19 vaccine's fate

US agencies are under pressure to take a call on the resumption of the use of Johnson & Johnson's COVID-19 vaccine.

20 Apr 2021


J&J seeks permission to conduct COVID-19 vaccine trial in India

US healthcare giant Johnson & Johnson said on Tuesday that it has sought approval from India's drug regulator to conduct a bridging clinical study of its single-dose COVID-19 vaccine in the country.

15 Apr 2021

South Africa

South Africa suspends Johnson & Johnson COVID-19 vaccine

South Africa has joined the US in suspending its roll-out of the Johnson & Johnson COVID-19 vaccine, following reports that six women who received the immunization doses had developed unusual blood clots with low platelet count.

13 Apr 2021


United States recommends 'pause' on J&J vaccine after clotting concerns

The United States government recommended a "pause" in the administration of the single-dose Johnson & Johnson (J&J) vaccine amid concerns of a "rare and severe type of blood clot."

09 Apr 2021


J&J set to begin India trial of its single-shot vaccine

US pharmaceutical giant Johnson & Johnson is in talks with the Indian government to soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the company said on Friday.

01 Apr 2021


15 million J&J vaccine doses ruined due to human error

About 15 million doses of Johnson & Johnson's one-shot vaccine have been ruined after a plant in the United States mixed up ingredients, The New York Times has reported.

28 Feb 2021


US FDA grants emergency use authorization for J&J's COVID-19 vaccine

The United States government on Saturday granted emergency approval to the COVID-19 vaccine developed by Johnson & Johnson, making it the third vaccine available to the public in the US.

25 Feb 2021


Johnson & Johnson's one-shot COVID-19 vaccine highly effective: FDA

Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released by US regulators that sets the stage for a final decision on a new and easier-to-use shot.

10 Feb 2021


Biological E aiming for 600 million J&J vaccine doses annually

Hyderabad-based pharmaceutical firm Biological E Ltd. is reportedly looking to contract-manufacture 600 million annual doses of the COVID-19 vaccine developed by Johnson & Johnson.

10 Feb 2021

South Africa

South Africa scraps AstraZeneca vaccine, will give J&J jabs

South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.

Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy

Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.

Bharat Biotech vaccine trials continued despite 'adverse event' in August

Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.

16 Nov 2020

Oxford University

Moderna's COVID-19 vaccine found to be 95% effective: Details here

American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

26 Sep 2020


Johnson & Johnson's single-dose COVID-19 vaccine induces strong immunity

Johnson & Johnson's COVID-19 vaccine has shown promise in early-to-mid-stage clinical human trials.

23 Sep 2020


Johnson & Johnson's COVID-19 vaccine goes into final human trials

In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.

06 Sep 2020


COVID-19 vaccine developers to pledge against rolling out shots prematurely

In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.

25 Jun 2020


Skin cream "Fair & Lovely" to drop "Fair" from name

Joining the bandwagon of brands that are making their products socially inclusive, the Indian unit of Unilever, Hindustan Unilever, has decided to drop "Fair" from the name of the skincare cream "Fair & Lovely," multiple reports said on Thursday.

J&J to begin human trials of COVID-19 vaccine in July

American pharma giant Johnson & Johnson has announced that it will be starting human trials of its experimental COVID-19 vaccine sooner than previously planned.

COVID-19 vaccine not guaranteed, says leading world health expert

With more than 160,000 deaths and 2.3 million infected cases globally, COVID-19 continues to wreak havoc around the world.

Johnson & Johnson: COVID-19's vaccine will be ready by 2021

American pharmaceutical giant Johnson & Johnson has announced that it has selected the lead vaccine candidate for the novel coronavirus disease COVID-19.

14 Mar 2020


Canadian firm announces coronavirus vaccine candidate; testing possible soon

As researchers globally race to develop a vaccine for the deadly novel coronavirus, a Canada-based biotechnology company on Thursday announced a vaccine candidate for the viral disease.

29 Jan 2019


Indian-born billionaire bribed doctors with strippers, to prescribe addictive painkiller

An Indian-born CEO of a pharmaceutical company based in the US is accused of practising illegal marketing tactics, including bribing doctors with lavish dinners and strip club parties, to prescribe a highly addictive opioid painkiller to patients.

J&J faulty hip-implants: SC closes case citing Center's compensation scheme

The Supreme Court today closed the case seeking action against US-based pharma major Johnson and Johnson for implanting faulty hip implants into patients in New Delhi.

SC seeks Center's response on faulty hip implants by J&J

The Supreme Court yesterday sought the Center's response on a plea alleging that "faulty" and "deadly" hip implants, made by US-based pharma major Johnson & Johnson (J&J), have been fitted into the bodies of 14,525 Indian patients, termed as "medical negligence" by an expert committee.

23 Sep 2018


J&J faulty implant case aftermath: Government mulling provision for compensation

The government is planning to bring a provision under which a medical device manufacturing company will have to offer monetary relief to patients in case of an adverse event.

Johnson & Johnson claims Indian victims' pleas are 'unreasonable'

Pharma giant Johnson & Johnson, which is facing lawsuit over its faulty hip implants, told National Consumer Disputes Redressal Commission (NCDRC) that demands of Indian patients were 'unreasonable and undue', as they filed the lawsuit only after knowing about the US settlement.

12 Aug 2018


Telangana attracts over Rs. 10,000cr in Life Sciences in 4yrs

Telangana, already home to pharma majors, attracted Rs. 10,222cr investments in the Life Sciences sector in the past four years, state IT and Industries Minister KT Ramarao said.

30 Mar 2018


Conservative attacks on #MarchForOurLives student leaders turn personal

Conservatives not comfortable with the politics of student leaders of Saturday's #MarchForOurLives have stooped to a new low, hurling personal attacks at the teen organizers calling for stricter gun-control measures.

24 Mar 2018


Mumbai battles tuberculosis: 50,000 cases reported in 3 years

Mumbai is still giving the government headaches when it comes to its rising tuberculosis cases.

03 Jul 2017

Health & Wellness

Artificial intelligence will aid in inventing drugs faster: Pharma companies

Humanity is making breakthroughs in every field of science and technology. At the same time, it's struggling to find a cure for something as paltry as the common cold.

06 May 2017


Johnson & Johnson to pay $110mn over talcum cancer-link

A US court has ordered Johnson & Johnson (J&J) to pay over $100 million to a woman who claimed she developed ovarian cancer after using its talcum powder for decades.

Johnson & Johnson buying Swiss biotech firm Actelion for $30bn

American healthcare major Johnson & Johnson (J&J) is acquiring Swiss biotech firm Actelion in a $30 billion all-cash deal.